tumor cancer
Research Topic
Language: English
This is a research topic created to provide authors with a place to attach new problem publications.
Research topics above this in the hierarchy
Research problems linked to this topic
- HNSCC is the sixth most common cancer worldwide.
- Breast cancer is the commonest solid tumor observed during pregnancy.
- Prostate cancer (PCa) is one of the most common malignant tumors in men.
- Prostate cancer is the most common cancer among men in the USA.
- Small cell lung cancer (SCLC) is an aggressive tumor, which can occur either de novo or from the histologic transformation of non-small cell lung cancer.
- Non-small cell lung cancer (NSCLC) metastasis commonly occurs in bone, which often results in pathological fractures.
- Lung cancer is one of the most common cancers; lung cancer is a malignant tumor that seriously threatens the lives of patients.
- Bladder cancer is the fifth most commonly diagnosed malignancy in the United States and one of the most prevalent worldwide.
- Patients with small cell lung cancer (SCLC) often suffer from relevant comorbidity.
- Discriminating indolent from clinically significant prostate cancer (PCa) in the initial biopsy setting remains an important issue.
- Non-small cell lung cancer is the most common type of lung cancer.
- Several studies have shown that the prevalence of breakthrough pain in cancer patients is high and it is a problem not fully solved.
- Head and neck cancer is the sixth most common cancer worldwide, with oral squamous cell carcinoma (OSCC) being the most representative type.
- Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer (LC).
- In Kenya, cancer is an increasing public health challenge, with an estimated 48,000 new cancer cases and over 33,000 deaths recorded each year.
- Gastrointestinal cancer, the most common solid tumor, has a poor prognosis.
- Emotional distress is common among cancer patients (25-30 %), as a result of the serious diagnosis and suffering from aggressive treatment.
- Androgen receptor (AR) signaling is a major driver of prostate cancer (CaP).
- Non-small cell lung cancer comprises the majority of lung cancer cases and is insensitive to chemotherapy.
- Despite the low overall incidence of testicular cancer, it is the most common malignancy among young men.
- Desmoplastic small round cell tumor (DSRCT) is a rare and highly aggressive tumor usually involving the peritoneum.
- The principal subtype of lung cancer, non small cell lung cancer (NSCLC) is a life threatening malignancy that causes high mortality rates.
- Non-small cell lung cancer (NSCLC) accounts for ~85% of all cases of lung cancer and TGF-β refractoriness is very common in NSCLC cells.
- Pituitary adenomas are the second most common primary brain tumor with invasive properties.
- Breast cancer is a heterogeneous disease characterized by diverse molecular signatures and a variable response to therapy.
- Senescent cells accumulation can contribute to the development of several age-related diseases, including cancer.
- Oral cancer is the sixth most common cancer among Indian males and the third most common cancer among Indian females.
- Childhood cancer as a life-threatening illness has negative consequences for both the patients and their family.
- Lung cancer is the leading cause of cancer-related deaths worldwide.
- Signet ring cell (SRC) histology is considered a poor prognostic factor in various cancers.
- Oral health care remains a serious unmet need of children and adolescents with cancer.
- Lung cancer is the most common cancer worldwide.
- Increased tumor size is a known risk for poor outcomes in patients with stage I and II non-small cell lung cancer (NSCLC), who are treated with surgery or radiotherapy.
- Three groups of men are at high risk of developing prostate cancer: men with a strong family history of prostate cancer, men of West African or Caribbean ancestry, and men with a germline pathogenic variant in a prostate cancer-associated gene.
- The struggle to combat cancer including the discovery of oncogenes, tumor suppressors, telomerase, and cancer stem cells has revealed the complex nature of cancer in humans.
- Survival rates for childhood cancer patients have improved dramatically, but the growing survivor population suffers from increased treatment-related toxicity including high risk for cardiovascular disease (CVD).
- Cyclin-dependent kinase 4 (Cdk4) represents a prime target for the treatment of cancer because most human cancers are characterized by overexpression of its activating partner cyclin D1, loss of the natural Cdk4-specific inhibitor p16, or mutation(s) in Cdk4's catalytic subunit.
- Although the ever-increasing number of cancer patients pose substantial challenges worldwide, finding a treatment with the highest response rate and the lowest number of side effects is still undergoing research.